Medtronic (NYSE:MDT) touted data today for its In.Pact Admiral drug-coated balloon in 2 sub-analyses of peripheral artery disease patients in the company’s In.Pact Global Study. The data were presented at the 2017 Charing Cross Symposium in London.
Researchers presented 1-year outcomes in patients with complex lesions, as well as outcomes in a subset of patients with complex, calcified lesions.
Get the full story at our sister site, Drug Delivery Business News.
The post Medtronic touts drug-coated balloon in peripheral artery disease patients appeared first on MassDevice.
from MassDevice http://ift.tt/2oI7itv
Cap comentari:
Publica un comentari a l'entrada